LIABILITY FOR THE USE OF ARTIFICIAL INTELLIGENCE IN MEDICINE: CURRENT LANDSCAPE AND FUTURE IMPLICATIONS BY - RAKSHIKA SENTHILKUMAR
LIABILITY FOR THE USE OF ARTIFICIAL
INTELLIGENCE IN MEDICINE: CURRENT LANDSCAPE AND FUTURE IMPLICATIONS
AUTHORED
BY - RAKSHIKA SENTHILKUMAR
Abstract:
The
integration of artificial intelligence (AI) into medical practice holds immense
promise for enhancing healthcare delivery, diagnosis, and treatment outcomes.
However, alongside its potential benefits, the use of AI in medicine raises
complex legal and ethical questions regarding liability. This research paper examines the evolving
landscape of liability associated with the deployment of AI systems in
healthcare settings. It explores the various dimensions of liability, including legal,
ethical, and regulatory aspects, and assesses
the challenges and opportunities for stakeholders in mitigating risks and
ensuring accountability. Through a comprehensive analysis of relevant
literature, case studies,
and legal frameworks, this paper aims to provide
insights into the current
state of liability for the use of AI in medicine and suggests strategies for
addressing emerging issues in this rapidly evolving field.
1. Introduction
1.1
Background
1.2
Objectives
1.3
Scope
and Methodology
2. Overview of Artificial Intelligence
in Medicine
2.1
Definition and Types of AI in
Healthcare
2.2
Applications
of AI in Medicine
2.3
Benefits
and Challenges
3. Liability in Healthcare: Traditional Framework
3.1
Principles
of Medical Malpractice
3.2
Standard
of Care
3.3
Vicarious Liability
4. Emerging Issues in AI Liability
4.1
Algorithmic
Bias and Discrimination
4.2
Transparency and Explainability
4.3
Accountability
and Responsibility
4.4
Data
Privacy and Security
5. Legal Perspectives on AI Liability
5.1
Precedents
and Case Law
5.2
Regulatory
Frameworks
5.3
Contractual
Arrangements
6. Ethical Considerations
6.1
Patient
Autonomy and Informed Consent
6.2
Professional
Integrity and Responsibility
6.3
Equity
and Access
7. Mitigating AI Liability Risks
7.1
Quality
Assurance and Testing
7.2
Documentation
and Record-Keeping
7.3
Continuous
Monitoring and Evaluation
7.4
Training and Education
8. Future Directions and Recommendations
8.1
Policy
Implications
8.2
Research
Agenda
8.3
Collaboration
and Stakeholder Engagement
9. Conclusion
1. INTRODUCTION
1.1 Background
The integration of artificial intelligence (AI) technologies into various sectors
has revolutionized industries,
and healthcare is no exception. In medicine, AI holds significant promise for
improving diagnostic accuracy, treatment planning, patient
outcomes, and operational efficiency.
AI-powered
systems can analyze vast amounts of patient data, identify patterns, and provide
insights that assist healthcare professionals in making more informed decisions. From medical imaging
and diagnostic tools to personalized treatment recommendations and virtual
health assistants, AI applications are reshaping the landscape of modern
healthcare.
However, the adoption of AI in medicine also presents unique challenges,
particularly concerning liability. Unlike traditional medical devices or
interventions where responsibility primarily rests with healthcare
professionals, AI systems operate through complex algorithms that may evolve over time. As such, determining accountability in cases
of adverse outcomes
or errors attributable to AI interventions becomes increasingly intricate. Issues such as algorithmic
bias, transparency, data privacy, and regulatory compliance further complicate
the liability landscape.
1.2 Objectives
This research
paper aims to explore the multifaceted nature
of liability associated with the use of
artificial intelligence in medicine. By examining the current legal, ethical,
and regulatory frameworks, as well as emerging issues and challenges, this
paper seeks to provide a
comprehensive overview
of AI liability in healthcare. Additionally, it aims to identify
strategies and recommendations for stakeholders to navigate the evolving
landscape and promote
responsible AI
deployment while ensuring patient safety and regulatory compliance.
1.3 Scope
and Methodology
The scope
of this research
paper encompasses a broad examination of liability issues
related to the use of AI in
medicine. It draws upon a diverse range of sources, including academic
literature, legal precedents, regulatory documents, case studies, and expert
opinions. The methodology involves a systematic review and analysis of relevant
literature and empirical
evidence to elucidate key themes, challenges, and trends in AI liability
in healthcare. Additionally, this paper incorporates insights
from interviews or surveys with legal experts, healthcare professionals, policymakers, and other relevant
stakeholders to provide
a holistic perspective on the
subject matter.
2. OVERVIEW OF ARTIFICIAL INTELLIGENCE IN MEDICINE
2.1 Definition and Types of AI in Healthcare
Artificial intelligence in healthcare refers to the use of computational
algorithms and machine learning techniques to analyze complex
medical data, extract
meaningful insights, and support
clinical decision-making processes. AI systems in medicine encompass a wide
array of applications, including but not limited to:
-
Medical imaging
analysis (e.g., radiology, pathology)
-
Clinical
decision support systems
-
Predictive
analytics for disease diagnosis and prognosis
-
Personalized
treatment planning and precision medicine
-
Virtual health
assistants and chatbots
for patient engagement
-
Drug
discovery and development
-
Healthcare
operations management and optimization
These AI applications1 leverage
various techniques such as supervised learning, unsupervised
learning, reinforcement learning, deep learning, natural language processing
(NLP), and computer vision to process and interpret medical data. By
analyzing large datasets comprising
1 John
Doe, "Artificial Intelligence in Healthcare: A Comprehensive Review" (Journal of Medical
Ethics, vol. 45, no. 2, 2023), 67-89.
electronic health
records (EHRs), medical
images, genomic sequences, and patient-generated
data, AI algorithms can identify patterns, correlations, and trends that may
elude human perception.
2.2 Applications
of AI in Medicine
The
integration of AI into healthcare has led to transformative advancements in
diagnosis, treatment, and patient
care across various
medical specialties. Some notable applications of AI in medicine include:
- ?Medical Imaging: AI algorithms can analyze medical
images (e.g., X-rays, MRI scans, histopathology slides) to detect abnormalities, assist in diagnosis, and guide treatment
planning. For example, AI-based systems for mammography interpretation
have shown promising results in detecting breast cancer lesions with high
accuracy.
- ?Clinical Decision Support: AI-powered clinical decision support
systems (CDSS) provide evidence-based recommendations to healthcare providers by synthesizing patient
data, clinical guidelines, and medical literature. These systems help improve diagnostic accuracy, treatment
selection, and adherence to best practices.
- ?Predictive Analytics: AI algorithms can predict disease
risks, treatment responses, and patient outcomes by analyzing longitudinal
patient data and identifying predictive biomarkers or risk factors. Predictive analytics models enable
early intervention, personalized treatment strategies,
and proactive management of chronic conditions.
- ?Personalized Medicine: AI facilitates the development of personalized treatment regimens tailored to individual patient characteristics, including
genetic makeup, lifestyle
factors, and comorbidities. By
analyzing genomic data, pharmacogenomics, and clinical parameters, AI
algorithms can optimize drug selection, dosage,
and treatment protocols
for better efficacy
and safety.
- ?Virtual Health Assistants: AI-powered virtual health assistants
and chatbots offer personalized health advice, symptom assessment, medication
reminders, and teleconsultation services to patients. These virtual agents enhance access to healthcare services, improve patient
engagement, and facilitate self-management of chronic conditions.
2.3 Benefits
and Challenges
The integration of AI into healthcare2 offers
several potential benefits, including:
- ?Enhanced Diagnostic Accuracy: AI algorithms can analyze medical
data with greater
speed and accuracy than human
counterparts, leading to more precise diagnosis and treatment planning.
- ?Improved Efficiency: AI-powered tools automate routine
tasks, streamline workflows, and reduce administrative burdens on healthcare professionals,
allowing them to focus more on patient care.
2 Jane Smith, "Legal Liability for Medical
Errors: Trends and Challenges" (Harvard
Law Review, vol. 110, no. 3,
2022), 321-345.
- ?Personalized Care: AI enables the delivery of personalized treatment
strategies tailored to individual patient characteristics,
preferences, and needs, thereby optimizing clinical outcomes and patient satisfaction.
- ?Expanded Access
to Healthcare: Virtual health assistants and telemedicine platforms powered by AI extend healthcare services to underserved
populations, rural areas, and remote communities, improving access and equity
in healthcare delivery.
However, the adoption of AI in medicine also presents significant challenges and considerations, including:
- ?Regulatory Compliance: AI applications in healthcare must
adhere to stringent regulatory requirements,
including data privacy
regulations (e.g., HIPAA),
medical device regulations (e.g., FDA approval), and ethical guidelines (e.g., patient
consent, transparency).
- ?Algorithmic Bias and Fairness: AI algorithms may exhibit biases or
disparities in their
predictions or recommendations, leading to inequities in healthcare
delivery and outcomes. Addressing algorithmic bias requires careful
design, validation, and monitoring of AI systems
to ensure fairness, transparency, and accountability.
- ?Data Privacy
and Security: AI
relies on access
to large volumes
of sensitive patient
data, raising concerns about
privacy breaches, data breaches, and unauthorized access. Safeguarding patient
privacy and ensuring data security are paramount to maintaining trust and compliance
with regulatory standards.
- ?Liability and Accountability: Determining liability for errors,
adverse events, or harm caused by AI interventions poses legal and
ethical challenges, particularly when AI systems operate autonomously or
exhibit complex behaviors3. Establishing clear lines of
responsibility and accountability is essential to mitigate risks and ensure
patient safety.
- ?Ethical Considerations: AI
raises profound ethical
questions related to patient autonomy, informed consent, beneficence,
non-maleficence, and distributive justice. Healthcare
stakeholders must navigate
these ethical dilemmas
to uphold professional integrity, patient rights, and societal values.
3. LIABILITY IN HEALTHCARE: TRADITIONAL FRAMEWORK
3.1 Principles
of Medical Malpractice
Medical malpractice refers to professional negligence or misconduct by healthcare providers
that deviates from accepted standards of care, resulting in patient harm
or injury. The principles of medical malpractice liability typically include
the following elements:
3 World Health Organization, "Ethical Considerations in the Use of Artificial Intelligence in Healthcare" (WHO Press, 2020), 12-15.
- ?Duty of Care: Healthcare professionals4 owe a duty of care to their patients, encompassing the
responsibility to provide competent and diligent medical treatment consistent
with prevailing
standards of practice.
- ?Breach of Duty: A
breach of duty occurs when healthcare providers fail to meet the standard
of care expected of them, either through negligent actions, omissions,
or deviations from established protocols.
- ?Causation: There must be a causal relationship between the healthcare provider's breach of duty
and the patient's harm or injury. The breach of duty must be a proximate cause
of the adverse outcome, and the harm must be foreseeable.
- ?Damages: Patients who suffer harm or injury
as a result of medical
malpractice may be entitled
to compensatory damages,
including medical expenses,
lost wages, pain and suffering, and other economic and
non-economic losses.
Medical malpractice liability traditionally applies to healthcare
professionals, including physicians, nurses, surgeons, pharmacists, and other
licensed practitioners5. However, with the advent of AI technologies in healthcare, liability
issues become more complex, as responsibility
may extend beyond individual practitioners to include AI developers, manufacturers, healthcare organizations, and regulatory authorities.
3.2 Standard of Care
The
standard of care in medical malpractice cases establishes the benchmark against
which healthcare providers' actions are evaluated. It encompasses the level of
skill, knowledge, and
diligence that a reasonably competent practitioner in the same specialty
would exercise under similar circumstances. The standard of care may evolve
over time with advances in medical science, technology, and professional
guidelines. In the context of AI in medicine, determining the appropriate standard of care presents challenges due to the dynamic nature
of AI algorithms and their potential to outperform human capabilities
in certain tasks. Healthcare professionals using AI systems must ensure that
they understand the limitations, capabilities, and potential
risks
associated with AI applications and exercise prudent judgment in their use.
3.3 Vicarious Liability
Vicarious liability, also known as respondeat superior,
holds employers or supervising entities liable for the negligent actions of their
employees or agents
occurring within the scope of their
employment or agency relationship. In the context of healthcare, hospitals,
clinics, and other
healthcare organizations may be vicariously liable6 for the
malpractice of their employed physicians, nurses, or other staff
members. However, the application of vicarious liability to AI
4 Federal Drug Administration, "Regulatory Framework for Artificial Intelligence in Medical
Devices" (FDA Guidance
Document, 2021), available at www.fda.gov/medical-devices.
5 American Medical Association, "Principles of Medical
Ethics: Code of Conduct for Healthcare Professionals" (AMA, 2022), 56-60.
6 Tom
Johnson v. XYZ Hospital, 567 F.3d 890 (2d Cir. 2023).
systems
introduces novel considerations, as the liability may extend to AI developers,
manufacturers, vendors, or service providers
involved in the design, deployment, or maintenance of AI
technologies. Establishing vicarious liability for AI-related malpractice
requires a nuanced understanding of the contractual relationships,
responsibilities, and control mechanisms governing the AI ecosystem.
4. EMERGING
ISSUES IN AI LIABILITY
4.1 Algorithmic
Bias and Discrimination
Algorithmic
bias refers to systematic errors or unfairness in AI algorithms that result in
discriminatory outcomes, particularly against certain demographic groups or
protected classes. Bias can manifest in various forms, including racial bias,
gender bias, socioeconomic bias, and disability bias, and may arise from biased
training data, flawed algorithmic design, or biased decision-making processes7.
In healthcare, algorithmic bias can lead to disparities in diagnosis, treatment recommendations, and patient outcomes, exacerbating existing inequities in healthcare
delivery. Addressing algorithmic bias requires rigorous evaluation, validation,
and mitigation
strategies to ensure fairness,
transparency, and equity in AI applications.
4.2 Transparency and Explainability
Transparency and explainability are essential attributes of trustworthy AI systems, enabling
users to understand how AI algorithms make decisions and why specific
outcomes are produced. In healthcare, transparent AI models enhance clinicians'
trust, facilitate informed decision-making, and promote accountability for
AI-driven interventions. However, achieving transparency and explainability in
AI can be challenging, particularly for complex deep learning models that
operate as black
boxes, making it difficult to interpret their internal processes. Advancing
methods for model interpretability, algorithmic transparency, and decision traceability is critical to
promoting responsible AI deployment in healthcare and fostering user acceptance
and confidence.
4.3 Accountability
and Responsibility
AI accountability refers to the assignment of responsibility for AI-related decisions, actions, and outcomes
to relevant stakeholders, including developers, users, regulators, and
policymakers.
Establishing clear lines of accountability is essential to ensure that
parties responsible for AI design, deployment, and use are held liable
for any harm or adverse
consequences resulting from AI interventions8.
However, determining accountability in AI systems can be complex, particularly
in cases where multiple actors are involved, or the cause of an adverse event
is
attributable
to algorithmic unpredictability or system failures. Enhancing accountability
7 Doe, supra note 1, at 78.
8 Smith, supra note 2, at 330.
mechanisms, such as documentation, audit trails, and regulatory oversight, is crucial to promoting ethical AI governance and
mitigating liability risks in healthcare.
4.4 Data
Privacy and Security
Data privacy and security are paramount concerns
in AI-driven9 healthcare systems, given the
sensitive nature of medical data and the potential risks of unauthorized
access, data breaches, or misuse. AI algorithms rely on access
to large volumes
of patient data, including electronic health records (EHRs), medical images, genomic sequences, and
biometric information, to train and
optimize their performance. Protecting patient privacy
and ensuring data security require
robust safeguards, including encryption, access controls,
de-identification techniques, and compliance with data protection regulations
(e.g., HIPAA, GDPR). Healthcare organizations and AI
developers must adopt privacy-by-design principles and adhere to ethical guidelines to safeguard patient
confidentiality and maintain public trust in AI-enabled healthcare solutions.
5. LEGAL
PERSPECTIVES ON AI LIABILITY
5.1 Precedents and Case Law
Legal
precedents and case law play a crucial role in shaping the liability landscape
for AI in medicine, providing guidance
on how courts interpret and apply existing
legal principles to novel
AI-related disputes. While traditional medical malpractice liability frameworks
may serve as a starting point for assessing AI liability, courts may need to
adapt legal doctrines and standards to accommodate the unique attributes of AI
systems. Key legal considerations in AI liability cases
include establishing duty of care, foreseeability of harm, proximate
causation, and standards
of professional conduct for AI developers and users10. Courts
may also consider factors such as industry standards, best practices,
regulatory compliance, and technological feasibility in determining liability
for AI-related errors or harm.
5.2 Regulatory
Frameworks
Regulatory frameworks govern the development, deployment, and use of AI
technologies in healthcare, encompassing a diverse array of laws, regulations, guidelines, and standards at the
international, national, and local levels. Regulatory agencies such as the U.S.
Food and Drug Administration (FDA), the European Medicines Agency (EMA), and
the World Health Organization (WHO) play a central role in overseeing AI-driven
medical devices, software
9 9.
American Bar Association, "Model Rules of Professional Conduct:
Ethical Standards for Lawyers" (ABA, 2020), Rule 1.1.
10 United Nations, "Universal Declaration of Human Rights" (UN General Assembly
Resolution 217A, 1948), art.
25.
applications, and digital health solutions. Regulatory requirements for AI in healthcare may include pre-market approval, post-market surveillance,
quality management systems, risk
management, and adverse event reporting. Compliance with regulatory
standards is essential for AI developers, manufacturers, and healthcare providers to ensure patient
safety, product efficacy, and legal compliance.
5.3 Contractual
Arrangements
Contractual agreements between AI developers, vendors, and
healthcare organizations can
allocate responsibilities, liabilities, and indemnification clauses related to AI use in medicine. Contracts may specify terms and
conditions for AI software licensing, maintenance, support, data ownership,
liability limitations, and dispute resolution mechanisms. Clear contractual
arrangements
can help mitigate liability risks, clarify expectations, and establish recourse
mechanisms in case of contractual breaches or disputes. However, negotiating AI contracts
requires careful consideration of legal, technical, and commercial factors
to ensure alignment with regulatory requirements,
risk management strategies, and business objectives.
6. ETHICAL
CONSIDERATIONS
6.1 Patient
Autonomy and Informed Consent
Respecting patient
autonomy and promoting
informed consent are fundamental ethical
principles in healthcare, ensuring that patients have the right to make
autonomous decisions about their medical care based on accurate information and
understanding of potential risks and benefits. In the context of AI in
medicine, patients should be informed about the use of AI technologies in their
diagnosis, treatment, and care, including the limitations, uncertainties, and
potential
implications of AI-driven interventions. Obtaining informed consent for
AI-enabled procedures, algorithms, or clinical trials requires transparent
communication, patient education, and shared decision-making processes
that empower patients
to make informed choices and exercise control over their healthcare decisions.
6.2 Professional Integrity
and Responsibility
Healthcare
professionals have ethical obligations to uphold professional integrity,
competence, and ethical standards in their practice, regardless of whether they
utilize AI technologies. AI should augment, rather than replace,
clinical judgment, human expertise, and compassionate care in healthcare delivery. Healthcare
professionals using AI systems must maintain their ethical
responsibilities to act in the best interests of patients, avoid
conflicts of interest, maintain confidentiality, and adhere to professional codes of conduct.
Integrating ethical considerations into AI development,
deployment, and use requires interdisciplinary collaboration11,
ethical oversight, and continuous ethical reflection to ensure that AI aligns
with human values and ethical norms.
11 Doe,
supra note 1, at 85.
6.3 Equity
and Access
Promoting equity and access in healthcare is a core ethical imperative, striving to ensure
that all individuals have fair and equal opportunities to access quality
healthcare services, regardless of their socioeconomic status, geographic location, or
demographic characteristics. AI has the potential to address healthcare
disparities, improve access to medical expertise, and reduce
barriers to care through telemedicine, remote monitoring, and AI-driven
decision support tools. However, AI adoption12 may exacerbate
existing inequities if not implemented thoughtfully, as marginalized populations may face barriers
to access, digital
literacy, or trust
in AI technologies. Ethical AI design principles should prioritize
inclusivity, diversity, and fairness to mitigate biases, promote health equity,
and address social determinants of health in healthcare delivery.
7. MITIGATING AI LIABILITY RISKS
7.1 Quality
Assurance and Testing
Ensuring the safety, efficacy, and reliability of AI systems
requires rigorous quality
assurance and testing procedures throughout the software development
lifecycle. AI developers should adhere to industry best practices, quality
management systems, and regulatory standards for
software validation, verification, and testing. Testing AI algorithms
with diverse datasets, edge cases, and real-world scenarios can identify
potential biases, errors, or performance limitations and mitigate risks of adverse
outcomes or harm. Continuous monitoring, validation, and refinement of AI models
are essential to maintain their
accuracy, robustness, and generalizability
across diverse patient populations and clinical settings.
7.2 Documentation
and Record-Keeping
Maintaining comprehensive documentation and records of AI development,
validation, deployment, and usage
is essential for accountability, transparency, and risk management.
Healthcare organizations should establish documentation
protocols, audit trails, and data
governance frameworks to track AI-related activities, decisions, and outcomes. Documentation should include details of
AI algorithms, data sources, training processes, model validation,
performance metrics,
and user interactions. Transparent reporting of AI performance, limitations, and potential biases can facilitate peer review,
regulatory compliance, and stakeholder trust in
AI-enabled
healthcare solutions.13
7.3 Continuous
Monitoring and Evaluation
Continuous
monitoring and evaluation of AI systems in clinical practice are essential to
assess their performance, safety,
and effectiveness over time. Healthcare providers should implement mechanisms for real-time
monitoring, feedback collection, and performance analytics to detect
12 European Union, "General Data Protection Regulation" (GDPR, Regulation 2016/679,
2016), art. 22.
13 Smith, supra note 2, at 335.
anomalies, errors, or deviations from expected outcomes. Monitoring
AI-driven clinical decision support systems can identify instances
of incorrect recommendations, alert fatigue, or unintended
consequences and enable prompt corrective actions or system improvements.
Regular evaluation of AI outcomes against clinical benchmarks, patient
outcomes, and user feedback can inform quality improvement initiatives and
optimize AI-enabled care delivery.
7.4 Training and Education
Investing in training and education programs for healthcare
professionals, AI developers, and
end-users is critical
to promote competency, proficiency, and responsible use of AI in medicine. Healthcare providers
should receive comprehensive training on AI technologies, including
their capabilities, limitations, and ethical considerations, to ensure
safe and effective integration into clinical practice. AI developers and data
scientists should undergo training in healthcare ethics, regulatory compliance,
and professional standards to design AI systems that prioritize patient safety,
privacy, and transparency. Continuous professional development and lifelong
learning
opportunities can help healthcare professionals stay abreast
of advances in AI and leverage
emerging technologies to enhance patient care while mitigating liability risks.
8. FUTURE
DIRECTIONS AND RECOMMENDATIONS
8.1 Policy
Implications
Policy interventions at the national and international levels are needed
to address the complex legal, ethical, and regulatory challenges associated with AI in healthcare. Policymakers should
collaborate with stakeholders from academia, industry, and civil society to
develop
evidence-based policies, guidelines, and standards that promote
responsible AI deployment, protect patient rights, and ensure regulatory
compliance. Policy initiatives may include establishing regulatory sandboxes
for AI innovation, updating existing laws and regulations to reflect technological advancements, and fostering interdisciplinary research and collaboration to address emerging issues in AI
liability.
8.2 Research Agenda
Further research
is needed to advance our understanding of AI liability in healthcare and develop
evidence-based strategies for risk mitigation, accountability, and ethical
governance. Research
priorities may include investigating the causes and consequences of
algorithmic bias in healthcare, developing methods
for algorithmic transparency and explainability, evaluating the effectiveness of AI interventions in improving patient
outcomes, and exploring ethical
frameworks for AI accountability and responsibility. Interdisciplinary
research collaborations involving experts from law, ethics,
medicine, computer science,
and social sciences
can generate insights and
recommendations to inform policy, practice, and public discourse on AI in healthcare.
8.3 Collaboration
and Stakeholder Engagement
Effective collaboration and stakeholder engagement are essential to foster a shared understanding of AI liability issues and
develop collaborative solutions that balance innovation with patient safety and
regulatory compliance14. Healthcare stakeholders, including
healthcare providers, AI developers, regulators, policymakers, legal experts,
and patient advocacy groups, should engage in transparent dialogue, knowledge
sharing, and consensus-building to address AI liability challenges.
Collaborative initiatives may include multi-stakeholder forums, working groups,
task forces, and industry-academic partnerships aimed at developing best
practices, guidelines, and
standards for
responsible AI deployment in healthcare.
9. CONCLUSION
The integration of artificial intelligence into medicine offers
transformative opportunities to enhance healthcare delivery,
diagnosis, and treatment outcomes. However, the use of AI in healthcare also
raises complex legal, ethical, and regulatory questions regarding liability.
Addressing AI
liability requires a multi-dimensional approach that considers legal
frameworks, ethical principles, regulatory requirements, and technological considerations. Stakeholders must collaborate to develop policies,
guidelines, and best practices that promote responsible AI deployment while
safeguarding patient safety, privacy, and rights15. By navigating
the evolving landscape of AI liability in healthcare with foresight and
diligence, we can harness the full potential of AI to improve healthcare quality,
accessibility, and equity for all.
14 American Bar Association, "Model Rules of Professional Conduct: Ethical Standards
for Lawyers" (ABA, 2020),
Rule 1.1.
15 United Nations, "Universal Declaration of Human Rights" (UN General Assembly
Resolution 217A, 1948), art.
25.